z-logo
Premium
Are down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? ‐ A Cochrane Review summary with commentary
Author(s) -
Morone Giovanni
Publication year - 2021
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/1756-185x.13989
Subject(s) - medicine , rheumatoid arthritis , discontinuation , disease , oncology , alternative medicine , intensive care medicine , physical therapy , pathology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom